Although little is known about the mechanisms that contribute to ovarian cancer progression, epidermal growth factor receptor (EGFR or ErbB1) is overexpressed in up to 70% of ovarian cancer [16], [17], [18]. Here, EGFR is linked to ovarian carcinoma.